Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 443 (TSXV: $IGX.V)
(OTCQB: $IGXT) (CSE: $BEV.C)(OTCQB: $WRHLF)
Delta, Kelowna, BC, July 20, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/07201IGX-BEV-WRHLF.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public and private company announcements.
IntelGenx
Corp. (TSX-V:IGX)(OTCQB:IGXT) today
announced that it and Tilray, Inc. have amended the exclusivity
terms of their November 2018 license, development and supply agreement to allow
for IntelGenx’s co-development and commercialization of CBD products with
additional partners. In consideration, IntelGenx shall pay a royalty to Tilray
on all CBD products sold pursuant to this amendment. All other terms of the
Agreement, including those pertaining to Tilray’s exclusive, worldwide
marketing and distribution rights for non-CBD cannabis-infused VersaFilm®,
remain unchanged.
“Since obtaining our cannabis
micro-processing license from Health Canada a few weeks ago, we have received
numerous expressions of interest from cannabis industry players in our drug
delivery platforms and manufacturing capabilities, as we continue to have the only
Health Canada licensed and GMP compliant facility for pharmaceutical film
manufacturing,” commented Dr. Horst G. Zerbe, CEO of IntelGenx. “While we
continue to work with Tilray® to align on the timing of a potential
commercial launch of our first co-developed cannabis-infused VersaFilm®
product, we are now actively seeking other potential partners to commercialize
CBD-containing film products targeting the health and wellness market in
Canada.”
Ikänik
Farms, Inc. announced
that Pideka SAS, a wholly owned
Colombian subsidiary of the Company, has signed a collaborative agreement with
CAS Biotechnology, for cannabis research on the potential medical benefits in
the treatment of COVID-19, with pharmaceutical grade cannabis oil provided by
the company's GACP and GMP-Pharma certified Casa Flores facility, located
outside of Bogota, Colombia. The company's cannabis is supported by
agronomically certified genetics and is currently sold in Colombia for use in
Formula Magistral.
"We are excited to partner with
CAS Biotechnology on the first export of pharmaceutical grade Cannabis to
Mexico, in hopes to aid in the treatment of COVID-19," said Borja Sanz de
Madrid, President of Ikänik International.
The testing will be conducted by CAS
Biotechnology's scientific team at their research facility in Mexico. CAS Biotechnology's
team is comprised of scientists with expertise in molecular and synthetic
biology, bioinformatics, genomics, proteomics, and pre-clinical trials. Pideka
will provide samples to CAS Biotechnology for conducting scientific research
and pre-clinical trials to determine the effect of Cannabis oil on SARS-CoV-2's
replication cycle.
"We are very proud to
participate in a study that brings medicine and cannabis closer together, in a
joint effort to discover possible Phyto therapeutic treatments, as a new course
of action for the treatment of COVID-19," said Brian Baca, CEO of Ikänik
Farms.
BevCanna
Enterprises Inc. (CSE:
BEV)
(OTC:
BVNNF) announced
today that it has entered into a non-binding letter of
intent to manufacture white-label CBD and THC-infused beverages for rising
British Columbian beverage brand State B Beverage Co. Launched by well-known
B.C. mixologist and Master Drink Maker Kelly Ann Woods, State B is part of the
Brujera Elixirs Incorporated house of brands which currently includes
Boozewitch (sober-curious mixers) and three additional functional human
performance drinks in development.
Under the proposed agreement,
BevCanna will leverage its extensive experience developing and launching
beverages in the Canadian market to create the new State B beverage concept,
which will be a merge of functional beverages and cannabis drinks. BevCanna
will also maintain responsibility for regulatory compliance with Health Canada.
State B will hold responsibility for
national sales and marketing efforts to launch the product line in Canada. The
white label agreement will be for an initial term of three years with a
subsequent three-year renewal option.
"The State B brand is an
intriguing new concept, and we're excited to be the ones to launch the new
line," said John Campbell, Chief Strategic Officer at BevCanna. "Our
plan to create a sustainable consistent revenue stream through our white-label
portfolio is well on track, and adding the State B brand will add to the
momentum."
"BevCanna's experience in
formulating functional yet very appealing beverages was exactly what we were
looking for in a white-label partner," said Kelly Ann Woods, CEO of
Brujera. "Their success in bringing great concepts to life, while
maintaining strict regulatory compliance, convinced us that they were the right
partner to work with on our new brand."
World
High Life
(OTCQB:
WRHLF) announced having
seen considerable sales numbers lead to two substantial quarters of growth from
its wholly owned subsidiary, Love Hemp.
Tony Calamita, the Chief Executive Officer (CEO) of Love Hemp, a
London-based CBD company spearheading the development of the United Kingdom’s
(UK) leading range of trusted CBD products, has the company hitting on all
cylinders as it heads into the second half of the year.
Although the global COVID-19 crisis
has many businesses treading water and searching for answers, Love Hemp hasn’t
missed a beat while meeting these trying times head on, the company has thrived
by giving customers exactly what they want—plenty of online options and
continued product development.
Love Hemp has over 80 products,
including oils, sprays, edibles, cosmetics, and vapes, and the company
currently enjoys around 1,200 retail listings, but World High Life’s subsidiary
has no plans of stopping there. Love
Hemp prides itself on understanding market demand and developing new products
and brands that satisfy what consumers want most. Calamita says that new product development is
at the heart of everything the company does.
“We currently have 15 new products in the development stage, and we
remain committed to creating the UK’s leading range of trusted CBD products.”
Last week, one of those newly
developed brands was launched into the market.
World High Life announced Love Hemp’s new brand, Buzz Leaf, a host of
products aimed at younger consumers that include the release of four
broad-spectrum CBD infused e-liquids with added terpenes, and eventually the
launch of a full range of CBD products, including CBD oils and capsules. According to the company, the e-liquids
feature exotic flavors that contain 500mg of CBD.
Given the exponential growth that
the company’s e-commerce business has seen and the sheer number of customers,
who are not only finding Love Hemp online but continuing to come back again and
again, Love Hemp has redesigned its global online retailer, https://www.CBDOilsUK.com, a
premium CBD oil and cannabidiol supplier in the UK, to handle the overwhelming
demand. Calamita says that with the
launch of the Buzz Leaf products, there is now something for everyone on the
website.
Tony Calamita, discussing the
successful results that Love Hemp has enjoyed in Q1 and Q2 said, “The COVID-19
pandemic affected consumer markets and is accelerating existing trends within
the consumer sector. When the pandemic
began, we saw a shift in retail, which resulted in the acceleration of the
e-commerce market as consumer demand shifted to shopping online.
“As a result, we achieved a 107%
increase in online sales from January to May 2020. This was an incredibly strong period of sales
for Love Hemp, and while our strong growth usually comes from a wider variety
of sales channels, given the challenging business circumstances, our shift to
the expansion of our online products has enabled us to ensure our customers are
able to continue to purchase and to engage with us. We are focused on building
trust and credibility with our consumer base and to continue to innovate while
responding to evolving consumer demands.”
Sales of the company’s CBD oil, CBD
oil sprays, and CBD soft gel capsules are leading the way, but the timely
introduction of another new product, Love Hemp Immune, well ahead of schedule, is already growing in popularity
among customers. Love Hemp Immune is advertised as a blend of CBD,
essential vitamins, including vitamins C and D, and bilberry extract to
maintain a healthy immune system by supporting our body’s natural defenses.
Calamita added, “We’ve also seen a
greater interest in health and wellness as COVID-19 reinforced the importance
of being healthy and maintaining a strong, balanced immune system.
“Since its launch, Love Hemp Immune has been well received by
consumers. It was a product that was due to launch in the Winter of 2020, but,
instead, we worked around the clock to ensure that consumers could have access
to it much sooner as COVID-19 and a nationwide lockdown hit the UK, a time when
boosting our immune systems has rarely felt more urgent. It contains the
perfect combination of beneficial ingredients to help boost the body’s natural
defenses. The importance of being flexible and agile while responding to
consumer needs has never been more crucial.”
So, where does World High Life’s
subsidiary go in the second half of the year?
The announcement of the Buzz Leaf brand is certainly a good start and
defines what is likely Love Hemp’s plan to get those 15 products/brands that
are in development to market. Love
Hemp’s CEO says, “As retail stores begin to reopen, we’re focused on holistic
growth across all channels from retail to online. We are in conversations with all major retailers
in the UK, and we look forward to continued growth among our customer base,
while maintaining brand loyalty among consumers.”
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Contact Investorideas.com
800
665 0411
